Citation: Oncotarget. 2019, 10(6), 685
Author: Evans J.P.; Sutton P.A.; Jones R.P.; Fretwell V.L.; Tweedle E.M.; Costello E.; Palmer D.H.; Winiarski B.K.; Goldring C.E.; Copple I.M.; Kevin Park B.; Kitteringham N.R.; Ressel L.; Duckworth C.A.; Mark Pritchard D.; Lin Z.-X
Abstract: [This corrects the article DOI: 10.18632/oncotarget.25497.].
Erratum for: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer. [Oncotarget. 2018]
Link to PubMed record
